Viewing Study NCT02867735


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-03-02 @ 5:51 PM
Study NCT ID: NCT02867735
Status: COMPLETED
Last Update Posted: 2022-04-15
First Post: 2016-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Edema View
None Diabetic Macular Edema View
None Neovascular Age-related Macular Degeneration View
None Retinal Vein Occlusions View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Macular Edema View
None Diabetic Macular Edema (DME) View
None Neovascular age-related Macular Degeneration(AMD) View
None Retinal Vein Occlusions (RVO) View